Dismal Outcome of EBV-Positive Nodal T/NK-Cell Lymphoma: A Multicenter Retrospective Study
Clinical Lymphoma Myeloma and Leukemia · 2025
DOI: 10.1016/j.clml.2025.11.008 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2025. Verfasst von Satoshi Ichikawa und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University Faculty of Medicine, Sendai, Japan; Department of Hematology, T…. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Herpesvirus 4, Human, Lymphoma, Extranodal NK-T-Cell, Lymphoma, T-Cell. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Epstein-Barr virus (EBV)-positive nodal T- and natural killer (NK)-cell lymphoma (EB-nTNKL) is a newly defined, rare, and aggressive EBV-driven lymphoid malignancy that typically affects older individuals, predominantly male, of East Asian descent. It is characterized by a cytotoxic T-cell phenotype, with only a limited number of cases documented to date. METHODS: We performed a multicenter retrospective analysis of 11 patients diagnosed with EB-nTNKL via lymph node biopsy in Japan in order to better characterize its clinicopathological features and outcomes. RESULTS: The median age at diagnosis was 65 years (range 24-81), and most patients presented with advanced-stage (III/IV) disease, B symptoms, and high-risk International Prognostic Index scores. Elevated serum lactate dehydrogenase (median 614 U/L) and soluble interleukin-2 receptor (median 5247 U/mL) levels were observed in all cases. All cases expressed cytotoxic molecules (granzyme B and/or TIA-1), indicating a cytotoxic T/NK-cell phenotype, and 8 cases were CD8-positive. Responses to conventional chemotherapy were poor. The median overall survival was only 2.9 months, with 6 of 11 patients dying within 3 months of diagnosis. CONCLUSIONS: EB-nTNKL represents a distinct clinicopathological entity with a fulminant clinical course and profound chemoresistance, resulting in an extremely poor prognosis. However, differentiation from other EBV-associated T/NK-cell neoplasms, particularly those arising in younger patients, remains a diagnostic challenge and warrants further clinicopathological investigation. These dismal outcomes underscore an urgent need to develop more effective therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University Faculty of Medicine, Sendai, Japan; Department of Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan. Electroni…
- Department of Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan.
- Department of Hematology, National Hospital Organization Sendai Medical Center, Sendai, Japan.
- Division of Hematology and Cell Therapy, Yamagata University Faculty of Medicine, Yamagata, Japan.
- Department of Gastroenterology, Hematology and Clinical Immunology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
- Department of Hematology, Fukushima Medical University, Fukushima, Japan.
Zitieren
APA
Ichikawa, S., Fukuhara, N., Katsuoka, Y., Ishizawa, Y., Kamata, K., Fukatsu, M., Nagao, T., Murai, K., Yokoyama, H., Tamai, Y., Ikezoe, T., Ichinohasama, R., Ito, S., Takahashi, N., & Harigae, H. (2025). Dismal Outcome of EBV-Positive Nodal T/NK-Cell Lymphoma: A Multicenter Retrospective Study. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2025.11.008
Vancouver
Ichikawa S, Fukuhara N, Katsuoka Y, Ishizawa Y, Kamata K, Fukatsu M, et al. Dismal Outcome of EBV-Positive Nodal T/NK-Cell Lymphoma: A Multicenter Retrospective Study. Clinical Lymphoma Myeloma and Leukemia. 2025. doi:10.1016/j.clml.2025.11.008
BibTeX
@article{Ichikawa2025,
author = {Ichikawa, Satoshi and Fukuhara, Noriko and Katsuoka, Yuna and Ishizawa, Yuki and Kamata, Kosuke and Fukatsu, Masahiko and Nagao, Takayo and Murai, Kazunori and Yokoyama, Hisayuki and Tamai, Yoshiko and Ikezoe, Takayuki and Ichinohasama, Ryo and Ito, Shigeki and Takahashi, Naoto and Harigae, Hideo},
title = {Dismal Outcome of EBV-Positive Nodal T/NK-Cell Lymphoma: A Multicenter Retrospective Study},
journal = {Clinical Lymphoma Myeloma and Leukemia},
year = {2025},
doi = {10.1016/j.clml.2025.11.008}
}
EUVIMED